BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $2,769,000 | -35.9% | 23,350 | -25.5% | 0.03% | -22.5% |
Q4 2021 | $4,318,000 | -93.4% | 31,336 | -93.4% | 0.04% | -93.7% |
Q3 2021 | $65,771,000 | +23.7% | 473,478 | -13.6% | 0.63% | +33.8% |
Q2 2021 | $53,178,000 | +33.4% | 547,777 | -6.1% | 0.47% | +28.1% |
Q1 2021 | $39,873,000 | -29.2% | 583,367 | -11.3% | 0.37% | -29.1% |
Q4 2020 | $56,344,000 | +17.6% | 657,380 | -10.8% | 0.52% | -0.9% |
Q3 2020 | $47,912,000 | -38.9% | 736,989 | -31.2% | 0.53% | -44.9% |
Q2 2020 | $78,364,000 | +117.3% | 1,071,866 | +1.1% | 0.96% | +57.5% |
Q1 2020 | $36,068,000 | -41.9% | 1,059,893 | -7.0% | 0.61% | -29.7% |
Q4 2019 | $62,067,000 | +30.4% | 1,140,101 | -0.1% | 0.86% | +20.4% |
Q3 2019 | $47,613,000 | +1796.9% | 1,141,243 | +1891.3% | 0.72% | +309.7% |
Q2 2019 | $2,510,000 | – | 57,312 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
FNY Investment Advisers, LLC | 30 | $0 | 0.00% |